Abstract
An in vivo technique has been developed which simultaneously compares a skin blanching bioassay with drug content in human stratum corneum following topical application of four 0.05% beta-methasone dipropionate formulations. Bioavailability of drug from commercial cream and ointment formulations was assessed by quantification of drug content in tape-stripped stratum corneum and skin blanching in the treated skin site under occluded conditions. Tape-stripping removed stratum corneum to a varying degree between individuals but was consistent (35%) within an individual with all formulations, day to day. A correlation (r = 0.9935) between the amount of drug in the treated stratum corneum normalized for surface area and the corresponding skin blanching score was observed with four 0.05% betamethasone dipropionate formulations. Increasing the amount of drug in the tape-stripped stratum corneum correlated with an increased skin blanching score. Ointment formulations delivered more drug to the skin and produced greater blanching scores than the cream formulations. Topical corticosteroid content in the treated skin site can therefore be quantified and correlates well with the resulting pharmacodynamic activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
R. C. Cornell and R. B. Stoughton. The use of topical corticosteroids in psoriasis. Dermatol. Clin. 2(3):397–409 (1984).
B. Portnoy. Comparison of fluocinonide and betamethasone in the treatment of psoriasis and eczema. Acta Dermato-venereol. 52 (Suppl 67):72–73 (1972).
P. G. Goodwin, S. Hamilton, and L. Fry. A comparison of the effect of various topical active steroids on the clinical and histological features of psoriasis. Br. J. Dermatol. 89:61–66 (1973).
A. W. McKenzie and R. B. Stoughton. Method of comparing percutaneous absorption of steroids. Arch. Dermatol. 86:608–610 (1962).
J. K. Halebian, B. J. Poulsen, and K. H. Burdick. Development of fluocinonide gel: Correlation of in vitro assays, in vivo bioassays and clinical trials. Curr. Ther. Res. 22(5):713–721 (1977).
R. C. Cornell and R. B. Stoughton. Correlation of the skin blanching assay and clinical activity in psoriasis. Arch. Dermatol. 121:63–67 (1985).
B. W. Barry and R. Woodford. Comparative bio-availability of proprietary topical corticosteroid preparations; Vasoconstrictor assays on thirty creams and gels. Br. J. Dermatol. 91:323–338 (1974).
B. W. Barry and R. Woodford. Comparative bio-availability and activity of proprietary topical corticosteroid preparations: Vasoconstrictor assays on thirty-one ointments. Br. J. Dermatol. 93:563–571 (1975).
R. B. Stoughton. Are generic formulations equivalent to trade name topical glucocorticoids? Arch. Dermatol. 123:1312–1314 (1987).
A. F. Peplar, R. Woodford, and J. C. Morrison. The influence of vehicle composition on the vasoconstrictor activity of betamethasone 17-benzoate. Br. J. Dermatol. 85:171–176 (1971).
J. R. Gibson, J. M. Kirsch, C. R. Darley, S. G. Harvey, C. A. Burke, and M. E. Hanson. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations. Br. J. Dermatol. III (Suppl. 27):204–212 (1984).
K. H. Burdick. Various vagaries of skin blanching. Arch. Dermatol. 110:238–242 (1974).
D. Dupuis, A. Rougier, R. Roguet, C. Lotte, and G. Kalopissis. In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. J. Invest. Dermatol. 82:353–356 (1984).
A. W. McKenzie and R. M. Atkinson. Topical activities of betamethasone esters in man. Arch. Dermatol. 98:741–746 (1964).
J. Ostrenga, C. Steinmetz, and B. Poulsen. Significance of vehicle composition I: Relationship between topical vehicle composition, skin penetrability and clinical efficacy. J. Pharm. Sci. 60(8):1175–1179 (1971).
L. K. Pershing, R. L. Conklin, and G. G. Krueger. Assessment of the variation in percutaneous absorption with the skin sandwich flap model. J. Invest. Dermatol. 88:511 (1987).
D. Caron, C. Queille-Roussel, V. P. Shah, and H. Schaefer. Correlation between the drug penetration and skin blanching effect of topically applied hydrocortisone creams in human beings. J. Am. Acad. Dermatol. 23(3):458–462 (1990).
J. Pouslen and H. Rorsman. Ranking of glucocorticoid creams and ointments. Acta Derm. Venerol. 60:57–62 (1980).
M. F. Coldman, L. Lockerbie, and E. A. Laws. The evaluation of several topical corticosteroid preparations in the blanching test. Br. J. Dermatol. 85:381–387 (1971).
J. Ostrenga, J. Halebian, B. Poulsen, B. Ferrell, N. Mueller, and S. Shastri. Vehicle design for a new topical steroid, fluocinonide. J. Invest. Dermatol. 56:392–399 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pershing, L.K., Silver, B.S., Krueger, G.G. et al. Feasibility of Measuring the Bioavailability of Topical Betamethasone Dipropionate in Commercial Formulations Using Drug Content in Skin and a Skin Blanching Bioassay. Pharm Res 9, 45–51 (1992). https://doi.org/10.1023/A:1018975626210
Issue Date:
DOI: https://doi.org/10.1023/A:1018975626210